Vor Biopharma VOR
NASDAQ VOR
$18.26 -0.68 (-3.59%)
At close: Oct 23, 2026 · 4:00 PM EDT

Vor Biopharma (VOR) Sale and Maturity of Investments (2022 - 2026)

Updated

Analysis

Vor Biopharma (VOR) Sale and Maturity of Investments (2022 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Investments Sold (Qtr)
1 Eli Lilly 1,199.50 Bn 1,168.08 Bn 19.71 Bn -
2 Johnson & Johnson 635.17 Bn 555.03 Bn 17.30 Bn 308.00 Mn
3 AbbVie 504.69 Bn 477.85 Bn 12.70 Bn -
4 Merck 358.43 Bn 312.86 Bn 12.21 Bn 1.30 Bn
5 Novartis Ag 288.36 Bn 252.75 Bn 11.24 Bn 136.00 Mn
6 Astrazeneca 265.78 Bn 239.54 Bn 12.86 Bn -
7 Amgen 237.46 Bn 192.86 Bn 7.24 Bn -
8 Gilead Sciences 193.65 Bn 167.76 Bn 6.22 Bn 1.03 Bn
9 Pfizer 171.05 Bn 118.00 Bn 10.94 Bn 2.12 Bn
10 Vor Biopharma 994.36 Mn -588.96 Mn - 42.59 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 42.59 Mn
Mar 31, 2026 13.31 Mn
Dec 31, 2025 5.00 Mn
Jun 30, 2025 -1,000.00
Mar 31, 2025 1,000.00
Jun 30, 2024 53.00 Mn
Mar 31, 2024 54.00 Mn
Dec 31, 2023 27.00 Mn
Sep 30, 2023 41.00 Mn
Jun 30, 2023 49.00 Mn
Mar 31, 2023 30.00 Mn
Dec 31, 2022 21.43 Mn
Sep 30, 2022 13.00 Mn
API Access

Vor Biopharma Sale and Maturity of Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=sale-and-maturity-of-investments&ticker=VOR&period=max&api_key=YOUR_API_KEY